GENERAL COUNSEL
Sat, Feb 15, 2025
Feb 15
exercised or converted securities in DAWN
2,962 shares @ $0.00
Decreased holdings by -12.50%
Net across this filing: +23.10% (+7,440 shares)
Option Exercise
Sale tied to a same-time option exercise
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology